Skip to main content
. Author manuscript; available in PMC: 2009 Aug 31.
Published in final edited form as: Neurol Clin. 2007 Aug;25(3):611–v. doi: 10.1016/j.ncl.2007.03.009

TABLE 2.

Characteristics of the whole genome linkage and association studies in AD.

Study
Ref.
Authors Study
Type
Sample Source Sample
Type
Age at
Onset
Sample Size Analytic
Approach
# Markers Marker
Density
Subset analysis
117 Pericak-Vance et al. A US (NIA, Duke, UCLA, MGH) multiplex families ≥60 16 families (52 ADs vs. 83 controls) ARP, ASP, LOD3 280 microsatellites 10–15 cM E4+ (all ADs with ≥ 1 E4 = 27 families) vs. E4− (≥1 AD member without E4 =27 families)5
117 ibid. follow-up A 38 families (89 ADs vs. 216 controls)
118 Pericak-Vance et al.6 D US (NIA, Duke, UCLA, MGH) multiplex families >60 16 families (52 ADs vs. 83 controls) ARP, ASP, LOD 280 microsatellites 10–15 cM
118 ibid. follow-up D 38 families (89 ADs vs. 216 controls)
119 Zubenko et al. B US (Belmont, Pittsburgh) case-control >60 100 AD cases (autopsied) vs. 100 controls (50 autopsied, 50 90+) Chi-square 391 microsatellites 10 cM
120 Kehoe et al. D US (NIMH) sibpairs ≥65 292 sibpairs (230families) ASP 237 microsatellites 16.3 cM
121 Pericak-Vance et al.7 A US (NIMH, NIA, Duke, UCLA, Vanderbilt) families >60 466 families (1051 ADs vs. 591 controls; 199 families autopsied) ARP, ASP 326 microsatellite 10 cM Autopsied (N=199) vs. Not (N=267)
122 Curtis et al.8 C US (NIMH) families most ≥65 241 families Conditional non-parametric linkage 237 microsatellites 16.3 cM
123 Hiltunen et al. B Finland case-control >60 47 ADs vs. 51 controls Chi-square 366 microsatellites 10 cM
124 Bacanu et al.9 C US (NIMH) families1 ≥65 65 families (42 with E4+) ARP (LOAD+psychosis) 237 microsatellites 16.3 cM E4+ (≥2 members with E4+)
125 Li et al.10,11 C US (NIMH, NIA, Duke, UCLA, Vanderbilt) families ≥49 449 families (1121 ADs vs. 746 controls) QTL (AAO)3 323 microsatellite 10 cM
126 Mayeux et al.12 A Caribbean Hispanics families mixed (>65 and ≤65) 79 families (320 subjects) ARP 35 markers (Ch12) 3.4 cM Late-onset (≥ 65) vs. Early/Mixed onset (<65); E4+ (≥75% of ADs with ≥1 E4) vs. E4− (<75% of ADs with ≥ 1 E4)
127 Myers et al.2 A US (NIMH, NIA)UK sibpairs ≥65 451 sibpairs (174 new from ref. 120) ASP 328 microsatellites (91 additional to ref. 120) 5 cM (select regions) E4+ (each sib with ≥ 1 E4= 280 ASP) vs. E4− (all E4−/E4− = 76 ASP)
128 Olson et al.9 C US (NIMH) sibpairs ≥60 272 sibpairs ASP with covariates (age, ApoE) (see 4) (see 4)
129 Blacker et al.8 A US (NIMH) families ≥50 437 families (994 AD vs. 445 controls; 238non-Kehoe families) ARP, LOD 381 microsatellites 9 cM Late-onset (≥65) vs. Early/Mixed onset (<65)
130 Farrer et al.13 B Inbred Arab community case-control ≥60 5 ADs vs. 5 controls Chi-square 375 microsatellites 10 cM
130 ibid. follow-up B 100 ADs vs. 110controls
131 Scott et al.14 C US (NIMH, NIA, Duke, UCLA, Vanderbilt) families ≥49 437 multiplex families (1014 ADs vs. 238controls) Ordered subsets analysis 336 microsatellites 10 cM
132 Lee et al. A Caribbean Hispanics families mixed (>65 and ≤65) 96 families (490subjects; 237 ADs vs.157 controls, others unknown); 104 families (2nd stage, 521 subjects) ASP, ARP, Affected only dominant model 340 microsatellites 10.2 cM Late-onset (≥65) vs. Early/Mixed onset (<65)
132 ibid. follow-up A 104 families (521subjects) additional markers on Ch 10, 18, 12
133 Avramopoulos et al.15 C US (NIMH) families >50 148 families (348 ADs vs. 153 controls) ASP with covariates (delusions, hallucinations) 381 microsatellites 9 cM Late-onset (>65) vs. Early onset (<65)
134 Holmans et al.16 C US (NIMH, NIA) UK sibpairs ≥65 453 sibpairs (600–789 subjects depending on covariate) ASP with covariates (mean AAO, difference AAO, mean ROD, difference ROD)3 328 microsatellites (91 additional to ref. 120) 5 cM (select regions)
135 Hahs et al. A US (Amish) extended families ≥58 5 families (115 subjects; 40 AD, 9 MCI, 66 controls) LOD 407 microsatellites 7 cM
136 Sillen et al. A Sweden multiplex and sibpair families ≥65 71 families (188subjects) ARP 365 microsatellites 9 cM E4+ = all ADs with ≥ 1 E4 vs. E4− = ≥ 1 AD without any E4 (in E4− families, the E4+ individuals were excluded from analysis)

Explanation of study types:

A: Linkage analysis of families, relative pairs, independent studies

B: Association analysis of case-controls, independent studies

C: Linkage analysis of families, using alternative analytical methods on largely overlapping datasets with previously published results D: First stage linkage results or results on subsets of other datasets

Explanation of superscripts:

1

Families with ≥ 2 members with LOAD and psychosis and ≥ 2 members with ApoE e4+

2

Follow-up study of 120; 80% sample overlap with 121

3

ARP=affected relative pair; ASP=affected sibpair; LOD=parametric linkage; QTL=quantitative trait loci; AAO=age at onset; ROD=rate of decline

4

Likely same markers as ref. 120, but not mentioned explicitly in text.

5

E4 = ApoE e4

6

Appears to be same study as ref. 117

7

Sample overlaps with refs. 117, 118; 80% overlap with ref. 127

8

Sample overlap significantly with ref. 120

9

Subset of ref. 120

10

Only results for AD are used herein

11

Sample overlaps with other NIMH data, major overlaps with refs. 117, 118, 121

12

Subset of ref. 132

13

Ch12 results are not follow-up from stage I, but based on previous studies

14

Subset of 121

15

Sample overlaps with other NIMH data

16

Same dataset as ref. 127